Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Voltarol considers further exercise initiatives in 2017

Pain relief brand Voltarol is aiming to roll out further initiatives in 2017 to get the nation moving.

Voltarol manufacturer GSK partnered with the Mayor of London to fund the ‘Get Moving’ project, which ran in 2016 and promoted the health benefits of staying active in later life.

The campaign encouraged older Londoners to meet the government-recommended weekly levels of physical activity, GSK said.

Voltarol is an anti-inflammatory pain reliever, containing the active ingredient diclofenac. The range consists of topical gels and a patch.

Voltarol brand manager Charlotte Perry said the ‘Get Moving’ programme offered a “truly fresh approach” to improve the health of Londoners “no matter their age”.

“At Volterol we want to challenge people to think differently about their body pain and inspire them to take active care,” Ms Perry said.

For more information about Voltarol, contact 0800 783 8881.

How do you encourage older patients to exercise?

Related Content

Topics



Superintendent Pharmacist
Ayrshire
Salary: From £60,000.00 per year

Apply Now
UsernamePublicRestriction

Register

CD008532

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel